Status:
TERMINATED
Steroid Treatment for Sickle Cell Pain Crisis
Lead Sponsor:
Baylor College of Medicine
Conditions:
Sickle Cell Disease
Vaso-occlusive Crisis
Eligibility:
All Genders
8+ years
Phase:
PHASE3
Brief Summary
The painful episode is the most common problem experienced by children with sickle cell disease. Although various treatments are available during painful episodes, the medication most commonly given f...
Detailed Description
In the United States, 9% of African Americans have sickle cell trait and 1 in 600 has sickle cell disease. Vaso- occlusive crises in sickle cell disease remain a frequent cause of severe pain, leading...
Eligibility Criteria
Inclusion
- Sickle cell and acute pain Age 8 and up English or Spanish-speaking
Exclusion
- Fever greater than 101 Acute chest syndrome or pneumonia Other SS complications (sequestration, aplastic crisis) Other explanation for pain (chronic, AVN, surgical) History of GI bleeding, HTN, or hyperglycemia/DM
Key Trial Info
Start Date :
December 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 13 2008
Estimated Enrollment :
18 Patients enrolled
Trial Details
Trial ID
NCT00263562
Start Date
December 1 2005
End Date
June 13 2008
Last Update
July 7 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Texas Childrens Hospital
Houston, Texas, United States, 77030